Security report for bionorica.de
Bionorica SE · Healthcare · Germany
Bionorica SE is a well-established German company specializing in the development and production of rational phytotherapeutic medicines. With over 90 years of history and a workforce exceeding 2,200 employees, it holds a leading position in the healthcare sector focused on plant-based pharmaceuticals. The website provides comprehensive information about the company, its products, research, and career opportunities, targeting healthcare professionals, patients, and business partners. Technically, the site is built on Drupal 9, employs modern web technologies including Google Tag Manager and Usercentrics for consent management, and is optimized for mobile devices with good accessibility and SEO practices. Security posture is solid with HTTPS enforced and cookie consent implemented, though it lacks some advanced security headers and a public security policy or vulnerability disclosure. Overall, the domain registration and website content are consistent and trustworthy, reflecting a legitimate and professional business presence.
Scanned
NIS2 and GDPR posture
- GDPR outside view
- 28/ 100 · High
- Checks completed
- 6of 7
NIS2 Art. 21(2)
- (a) Risk analysis and security policies: Not visible from outside
- (b) Incident handling: One indicator
- (c) Business continuity, backups and crisis management: Not visible from outside
- (d) Supply chain security: Not visible from outside
- (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
- (f) Assessing the effectiveness of security measures: Not visible from outside
- (g) Cyber hygiene and security training: Not visible from outside
- (h) Cryptography and encryption: Partly checked
- (i) HR security, access control and asset management: One indicator
- (j) Multi-factor authentication and secured communications: Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
4 findings rated critical or high. Fix these first.
GDPR outside view
These are the privacy signals visitors and data protection authorities look for under GDPR.
- Critical
EU business without adequate privacy measures
EU businesses are subject to strict GDPR requirements
What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures
- High
No Cookie Policy found
GDPR requires clear information about cookie usage
What to do: Add a dedicated cookie policy explaining cookie usage and purposes
- High
No Cookie Consent Banner found
GDPR requires explicit consent for non-essential cookies
What to do: Implement a cookie consent banner that appears on first visit
- GDPR Art. 7
- ePrivacy Art. 5(3)
- NIST PT-4: NIST SP 800-53 Rev. 5 PT-4: Consent
- Critical
SSL/TLS
TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.
- Critical
Unable to retrieve SSL certificate
Could not establish secure connection to retrieve certificate information
What to do: Check if the server is accessible and SSL/TLS is properly configured
- Critical
Need hands-on remediation? Email guard@offseq.com
Keep watching bionorica.de
This scan found 15 issues across 5 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended€25per month
- TLS certificates and expiry
- DNS records
- SPF, DKIM and DMARC
- Security headers
- GDPR and NIS2 posture
- Exposed services
- Third-party trackers
- Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.
Full report
€39.90one-time
- The complete analysis as a PDF you can cite
- Email delivery with an unlock code
- Lifetime access to this report
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
- SSL/TLS
- 0
- Email security
- 80
- DNS health
- 70
- Network security
- 40
- GDPR outside view
- 28
- Average
- 44
Not counted
- Security headers: did not complete in this scan.
- NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
- OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
- The certificate is not trusted by browsers
- The website is not served over HTTPS
- A database, remote desktop, file-sharing or Telnet service is reachable from the internet
- The page loads a script from a compromised source
- The domain registration has expired
- SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
- Critical0–25
- High26–49
- Medium50–75
- Low76–100
Technical appendix
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
Security posture
Recommendations
- Implement and publish comprehensive security headers including Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options.
- Create and maintain a publicly accessible security policy and incident response contact information.
- Establish a vulnerability disclosure program or security.txt file to encourage responsible reporting.
- Enhance transparency by providing direct contact channels for security incidents or abuse.
- Regularly audit and update third-party libraries and consent management tools to maintain compliance and security.
Site observations
Automated reading of the public site. Ratings are indicative.
Business
- Company
- Bionorica SE
- Description
- Die Bionorica SE entwickelt und produziert rationale Phytotherapeutika, die sich gleichzeitig durch ihre hohe Wirksamkeit sowie ihre gute Verträglichkeit auszeichnen. Wir schaffen Bewusstsein für den Wert und die Wirksamkeit pflanzlicher Arzneimittel und machen die moderne Medizin jeden Tag ein Stück pflanzlicher.
- Key services
- Development and production of phytotherapeutic medicines, Research and development in phytopharmaceuticals, Information and education on plant-based medicines
- Content quality
- excellent
- Branding
- consistent
Technology
- Stack
- Drupal 9, Google Tag Manager, Usercentrics Consent Management, LazySizes (lazy loading images)
- Frameworks
- Drupal
- Performance
- moderate
- Mobile
- good
- Accessibility
- good
- SEO
- good
Security
- Observed score
- 85/100
- Good practices seen
- HTTPS enforced
- Cookie consent management implemented
- Whistleblower reporting channel available
Analytics and tracking
- Services
- Google Tag Manager
- Tracking level
- moderate
- Privacy practices
- good
Advertising
- Marketing tools
- Usercentrics Consent Management
- Transparency
- basic
Site quality
- Design
- excellent
- User experience
- excellent
- Content relevance
- excellent
- Navigation
- excellent
- Professionalism
- excellent
- Trustworthiness
- high
Key observations
- Website is fully accessible with rich content in German language.
- Strong focus on phytopharmaceutical products and company information.
- Comprehensive navigation structure with detailed product and health information.
- Cookie consent and privacy policy are implemented and GDPR compliant.
- No explicit security headers detected; room for improvement in security posture.
- No exposed sensitive data or suspicious links found.
- WHOIS data confirms domain legitimacy and consistency with business claims.
Technical notes
Notes
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
- MITRE CWE (opens in a new tab)4.20 (2026-04-30) · CWE Terms of Use (free use with attribution, © MITRE)
- OWASP Top 10:2025 (opens in a new tab)2025 (membership per CWE 4.20) · CC BY-SA 4.0
- MITRE CAPEC (opens in a new tab)3.9 (2023-01-24) · CAPEC Terms of Use (free use with attribution, © MITRE)
- OWASP ASVS (opens in a new tab)5.0.0 · CC BY-SA 4.0
- OWASP Web Security Testing Guide (opens in a new tab)latest (checklist.json, master) · CC BY-SA 4.0
- OWASP Secure Headers Project (opens in a new tab)2026-10-18 · Apache-2.0
- Mozilla Server Side TLS (intermediate) (opens in a new tab)6.0 · MPL-2.0
- NIST SP 800-53 Rev. 5 (OSCAL catalog) (opens in a new tab)5.2.0 · Public domain (US Government work)
- Directive (EU) 2022/2555 (NIS2) (opens in a new tab)OJ L 333, 27.12.2022 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Commission Implementing Regulation (EU) 2024/2690 (opens in a new tab)OJ L, 18.10.2024 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Regulation (EU) 2016/679 (GDPR) (opens in a new tab)OJ L 119, 4.5.2016 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Directive 2002/58/EC (ePrivacy), consolidated (opens in a new tab)19.12.2009 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- RFC Editor metadata (opens in a new tab)per-RFC (obsolete RFCs rejected) · IETF Trust Legal Provisions (metadata only)
- NIST CSRC, W3C TR, IETF Datatracker, EDPB, EUR-Lex CELLAR and gesetze-bayern.de (opens in a new tab)per document · Titles and links only
- NIST NVD CVE API 2.0 (opens in a new tab)live records · Public domain (NVD); CVE® records © MITRE, free use
- W3C WCAG 2.2 (opens in a new tab)W3C Recommendation (wcag.json) · W3C Software and Document License
- ETSI EN 301 549 (opens in a new tab)V3.2.1 (2021-03), clause headings · Clause numbers and titles only (© ETSI)
- Directive (EU) 2019/882 (European Accessibility Act) (opens in a new tab)OJ L 151, 7.6.2019 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
- Directive (EU) 2016/2102 (Web Accessibility Directive) (opens in a new tab)OJ L 327, 2.12.2016 · EUR-Lex reuse under Commission Decision 2011/833/EU (© European Union)
Retrieved 2026-10-25
Feedback on this report
Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.
Reviews of this site
Share your experience with bionorica.de. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review bionorica.de.